STERIS Stock: Hold or Sell?

STERIS stock has seen a 11.3% loss over the last six months, underperforming the S&P 500. The companys capital efficiency struggles, with a 5% average return on invested capital compared to top healthcare players 20%+ consistently. Shareholders are left questioning the long-term potential, as the stock trades at a fair but unexciting 20.1 forward price-to-earnings ratio. Downside risks outweigh potential upside, making it a less attractive investment compared to other options. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/a3fab156afb82355